The results of the phase 1 trial indicate that this oral medicine has excellent activity against the herpes virus. The newest study will compare the AiCuris drug against
Valtrex, an FDA approved medicine
for the treatment of genital herpes. For more information about research sites conducting this study, please contact AiCuris. Information Email: info-at-aicuris-dot-com
Finally, another therapeutic vaccine trial starting in October from a company called Agenus.